TABLE 2.
Comparison of Reciprocal Relationships between CAF and CD133+ or CD133− Colon Cancer Cells
| A. CD133+ vs. CD133− cells | |||
|---|---|---|---|
| RECEPTOR (Gene Symbol) | p-value | Fold Change | |
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.02* | 4.07 | 
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.04* | 3.12 | 
| ITGB8 | integrin, beta 8 | 0.01* | 2.18 | 
| FGFR2 | Fibroblast growth factor 2 | 0.03* | 1.21 | 
| LIGAND | |||
| CXCL12 | chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 0.89 | 1.02 | 
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.88 | 1.01 | 
| VTN | vitronectin | 0.82 | −1.04 | 
| FGF ligands 1,2,7,5,13, | fibroblast growth factor ligands | N.S. | |
| B. CAF vs. CD133+ or CD133− cells | |||
|---|---|---|---|
| LIGAND | CAF vs CD133+ p-value | CAF vs CD133+ Fold change | |
| CAF vs CD133− p-value | CAF vs CD133− Fold change | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 0.0003* | 3.73 | 
| 0.0002* | 3.8 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 3.71E-05* | 1.87 | 
| 4.01E-5* | 1.85 | ||
| VTN | vitronectin | 1.54E-05* | 7.29 | 
| 1.72E-05* | 7.03 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 1.49E-09* | 28.32 | 
| 1.48E-09* | 28.51 | ||
| FGF7 | fibroblast growth factor 7 (keratinocyte growth factor) | 3.52E-07* | 15.35 | 
| 3.52E-07* | 15.36 | ||
| FGF13 | fibroblast growth factor 13 | 3.26E-07* | 8.10 | 
| 5.22E-07* | 7.9 | ||
| FGF5 | fibroblast growth factor 5 | 2.83E-05* | 2.57 | 
| 3.50E-05* | 2.48 | ||
| FGF1 | fibroblast growth factor 1 | 7.48E-05* | 2.12 | 
| 3.53E-05* | 2.35 | ||
| C. CD133+ or CD133− Cells vs.CAF | |||
|---|---|---|---|
| RECEPTOR (GENE SYMBOL) | CD133+ vs. CAF p-value | CD133+ vs. CAF Fold change | |
| CD133− vs. CAF p-value | CD133− vs. CAF Fold change | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.007* | 5.26 | 
| 0.56 | 1.29 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.03* | 3.32 | 
| 0.89 | 1.06 | ||
| ITGB8 | integrin, beta 8 | 0.009* | 2.04 | 
| 0.73 | −.107 | ||
| FGFR2 | Fibroblast growth factor 2 | 0.005* | 1.48 | 
| 0.015* | 1.22 | ||
Statistical significance demonstrated at p-value ≤ 0.05